[HTML][HTML] Bridging the knowledge gaps in vaccine design

R Rappuoli - Nature biotechnology, 2007 - nature.com
Bridging the knowledge gaps in vaccine design | Nature Biotechnology Skip to main content
Thank you for visiting nature.com. You are using a browser version with limited support for …

Pertussis: a matter of immune modulation

D De Gouw, DA Diavatopoulos… - FEMS microbiology …, 2011 - academic.oup.com
Pertussis, or whooping cough, is a highly contagious, acute respiratory disease of humans
that is caused by the Gram-negative bacterial pathogen Bordetella pertussis. In the face of …

[HTML][HTML] Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

N Mielcarek, AS Debrie, D Raze, J Bertout… - PLoS …, 2006 - journals.plos.org
Pertussis is still among the principal causes of death worldwide, and its incidence is
increasing even in countries with high vaccine coverage. Although all age groups are …

[HTML][HTML] Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis

GS Kirimanjeswara, LM Agosto… - The Journal of …, 2005 - Am Soc Clin Investig
Whooping cough is considered a childhood disease, although there is growing evidence
that children are infected by adult carriers. Additionally, increasing numbers of vaccinated …

Immunodrugs: therapeutic VLP-based vaccines for chronic diseases

GT Jennings, MF Bachmann - Annual review of pharmacology …, 2009 - annualreviews.org
Worldwide, the prevalence of noncommunicable chronic diseases is increasing. The use of
vaccines to induce autoantibodies that neutralize disease-related proteins offers a means to …

Bordetella bronchiseptica and Bordetella pertussis: similarities and differences in infection, immuno-modulation, and vaccine considerations

B Miguelena Chamorro, K De Luca… - Clinical Microbiology …, 2023 - Am Soc Microbiol
Bordetella pertussis and Bordetella bronchiseptica belong to the genus Bordetella, which
comprises 14 other species. B. pertussis is responsible for whooping cough in humans, a …

A pilot clinical trial of a recombinant ricin vaccine in normal humans

ES Vitetta, JE Smallshaw, E Coleman… - Proceedings of the …, 2006 - National Acad Sciences
Ricin, a highly potent toxin produced by castor beans, is classified by the Centers for
Disease Control and Prevention as a level B biothreat because it is easily produced, readily …

Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines

A Seubert, U D'Oro, M Scarselli… - Expert review of vaccines, 2014 - Taylor & Francis
Pertussis toxin (PT) is one of the major virulence factors of Bordetella pertussis and the
primary component of all pertussis vaccines available to date. Because of its various …

International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United …

ML Tondella, GM Carlone, N Messonnier, CP Quinn… - Vaccine, 2009 - Elsevier
An international meeting on Bordetella pertussis assay standardization and harmonization
was held at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, 19–20 July …

Immunogenicity of a two-component (PT&FHA) acellular pertussis vaccine in various combinations

E Vidor, SA Plotkin - Human vaccines, 2008 - Taylor & Francis
Immunogenicity data for the pertussis components of the French diphtheria-tetanus-two
component acellular pertussis vaccine (DTaP2Fr) obtained after primary series of …